Grain-of-Rice device could end guesswork in skin treatment

NCT ID NCT07352566

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a tiny microdevice, about the size of a grain of rice, that holds up to 20 different FDA-approved skin medications. Placed directly on the skin, it releases very small amounts of each drug to see how the skin reacts. The goal is to find out if this device can safely predict which treatment will work best for a person with psoriasis or atopic dermatitis. Only 10 adults will take part, and the focus is on safety and whether the device can collect enough tissue for analysis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
in situ cutaneous microdevice
What this could lead to
If successful, this microdevice could help doctors quickly identify which medication works best for a person's skin condition, saving time and trial-and-error.
What could go wrong
This is a very small early-stage study (10 people) focused on safety and feasibility, not on proving treatment effectiveness. The device may not reliably predict real-world responses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California, San Francisco

    San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.